drugset / Trial / NCT07383363

Comparison of Efficacy and Safety of Vita 6 Versus Zinc Along With Applied Behavioural Therapy

NCT07383363

Completed 64 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

The study seeks to fill the gaps in available local data regarding the diagnosis and its management, as multiple treatments are in practice. Therefore, the study aimed at the comparison of efficacy and safety of Vita 6 versus zinc along with applied behavioral therapy in the management of autism spectrum disorder in children aged 3-14 years.

Timeline

Start
2025-09-23
Primary completion
2026-03-30
Completion
2026-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Vita 6 Unknown 50 mg
Subject Zinc Sulfate Unknown 2 mg/kg